347 related articles for article (PubMed ID: 34866938)
21. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
22. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage.
Wang RH; Wen WX; Jiang ZP; Du ZP; Ma ZH; Lu AL; Li HP; Yuan F; Wu SB; Guo JW; Cai YF; Huang Y; Wang LX; Lu HJ
Front Immunol; 2023; 14():1115031. PubMed ID: 36860868
[TBL] [Abstract][Full Text] [Related]
23. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
24. Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma.
Xu X; Jing J
Front Oncol; 2022; 12():900305. PubMed ID: 36338698
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment PLR Is Preferable to NLR and LMR as a Predictor in Locally Advanced and Metastatic Bladder Cancer.
Karan C; Yaren A; Demirel BC; Dogan T; Ozdemir M; Demiray AG; Taskoylu BY; Degirmencioglu S; Dogu G; Ozhan N; Cakiroglu U; Celikyurek A
Cancer Diagn Progn; 2023; 3(6):706-715. PubMed ID: 37927800
[TBL] [Abstract][Full Text] [Related]
26. The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.
Wang T; Lin H; Hsueh C; Lau HC; Zhou J; Gong H; Tao L; Zhou L; Wu C
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):453-463. PubMed ID: 35709701
[TBL] [Abstract][Full Text] [Related]
27. Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer.
Yang J; Deng M; Bi M; Wang Y; Qiao X; Zhang S
Future Sci OA; 2022 Mar; 8(5):FSO798. PubMed ID: 35662746
[TBL] [Abstract][Full Text] [Related]
28. Comparative Analysis of Inflammatory Indexes in Lung Cancer Patients With and Without Brain Metastases.
Tamas F; Tamas CI; Suciu BA; Manu DR; Cehan AR; Balasa AF
Cureus; 2024 May; 16(5):e60921. PubMed ID: 38910770
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma.
Kwon BS; Jeong DH; Byun JM; Lee TH; Choi KU; Song YJ; Suh DS; Kim KH
J Cancer; 2018; 9(7):1127-1134. PubMed ID: 29675093
[No Abstract] [Full Text] [Related]
30. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.
Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z
Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
32. Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.
Song D; Li X; Zhang X
Am J Transl Res; 2022; 14(5):3233-3239. PubMed ID: 35702097
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.
Li YX; Chang JY; He MY; Wang HR; Luo DQ; Li FH; Li JH; Ran L
J Oncol; 2021; 2021():2939162. PubMed ID: 34539781
[TBL] [Abstract][Full Text] [Related]
34. Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I-III) esophageal squamous cell carcinomas.
Chen C; Chen G; Wu Y; Li J
Transl Cancer Res; 2020 May; 9(5):3483-3490. PubMed ID: 35117713
[TBL] [Abstract][Full Text] [Related]
35. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.
Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X
J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763
[TBL] [Abstract][Full Text] [Related]
36. The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.
Song Q; Xu SX; Wu JZ; Ling L; Wang S; Shu XH; Ying DN; Pei WW; Wu YC; Sun SF; Zhang YN; Zhou SH; Shao ZY
Front Immunol; 2023; 14():1177403. PubMed ID: 37457691
[TBL] [Abstract][Full Text] [Related]
37. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD.
Luo Z; Zhang W; Chen L; Xu N
Int J Gen Med; 2021; 14():2839-2848. PubMed ID: 34211292
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
Zeng X; Liu G; Pan Y; Li Y
J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
Zheng C; Ye S; Liu W; Diao M; Li L
Front Oncol; 2023; 13():1276175. PubMed ID: 37901310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
